New Guideline Published for Congenital Muscular Dystrophy

NCBDDD’s Division of Human Development and Disability (DHDD) announces the publication of evidence-based guidelines for congenital muscular dystrophy. The new guidelines, developed by the American Academy of Neurology and the American Association of Neuromuscular & Electrodiagnostic Medicine, make recommendations for treating and managing complications such as breathing problems, heart problems, joint stiffness, cognitive problems, and seizures.

NCBDDD’s Division of Human Development and Disability (DHDD) announces the publication of evidence-based guidelines for congenital muscular dystrophy. The new guidelines, developed by the American Academy of Neurology and the American Association of Neuromuscular & Electrodiagnostic Medicine, make recommendations for treating and managing complications such as breathing problems, heart problems, joint stiffness, cognitive problems, and seizures. Muscular dystrophy has no cure, but acting early may help an individual get the services they need to reach their full potential.

Funded in part by a grant from DHDD, the guidelines also recommend that doctors evaluate symptoms, family history, physical exams, and results from lab tests to diagnose a person’s subtype of congenital muscular dystrophy. There are five main subtypes of congenital muscular dystrophy; however, genetic testing does not always lead to a confirmed diagnosis. The guidelines were published online and in the print edition of Neurology March 31, 2015

%d bloggers like this: